Abstract
Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the question whether physician gender plays a role in the quality of care has been debated for some time. For example, it has been postulated that the practice styles of female physicians, such as spending more time with a patient, hearing and listening more effectively, and including more preventive measures, may result in more efficient clinical encounters that may positively affect clinical outcomes. This narrative review examines the existing evidence regarding the effects of physician gender on the quality of care provided, focusing mainly on patients with cardiometabolic diseases.
Keywords: Physician gender, quality of care, cardiovascular disease, hypertension, diabetes mellitus, chronic heart failure, blood pressure, lipid control, cardiac catheterization, glycemic control
Current Pharmaceutical Design
Title: Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Volume: 17 Issue: 33
Author(s): I. Gouni-Berthold and H. K. Berthold
Affiliation:
Keywords: Physician gender, quality of care, cardiovascular disease, hypertension, diabetes mellitus, chronic heart failure, blood pressure, lipid control, cardiac catheterization, glycemic control
Abstract: Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the question whether physician gender plays a role in the quality of care has been debated for some time. For example, it has been postulated that the practice styles of female physicians, such as spending more time with a patient, hearing and listening more effectively, and including more preventive measures, may result in more efficient clinical encounters that may positively affect clinical outcomes. This narrative review examines the existing evidence regarding the effects of physician gender on the quality of care provided, focusing mainly on patients with cardiometabolic diseases.
Export Options
About this article
Cite this article as:
Gouni-Berthold I. and K. Berthold H., Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases, Current Pharmaceutical Design 2011; 17 (33) . https://dx.doi.org/10.2174/138161211798220954
DOI https://dx.doi.org/10.2174/138161211798220954 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology C-Reactive Protein and Atherosclerosis: An Update
Vascular Disease Prevention (Discontinued) Auraptene: A Natural Biologically Active Compound with Multiple Targets
Current Drug Targets Gene Patents in the Primary Prevention of Vascular Diseases
Recent Patents on DNA & Gene Sequences Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives
Current Pharmaceutical Design Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) A Review of the English and Russian Language Literature on the Osteoarticular Manifestations of Brucellosis Infection
Current Rheumatology Reviews Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews Editorial [Hot Topic: COX-2 Inhibition in Gastroenterology and Rheumatolgy:Current Challenges and Perspectives for the Future (Executive Editor: Angel Lanas)]
Current Pharmaceutical Design Different Omega-3 Formulations Yield to Diverse Clinical Response: A Case-Report
Current Drug Safety Increase in the Non-HIV-Related Deaths Among Aids Cases in the HAART Era
Current HIV Research Editorial (Thematic Issue: Cardiovascular Drug Therapy in Paediatric Age: From Metabolomics to Clinical Practice)
Current Medicinal Chemistry Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
Current Pharmaceutical Design Novel approaches to examine the regulation of voltage-gated calcium channels in the heart
Current Molecular Pharmacology Ezetimibe Therapy for Dyslipidemia: An Update
Current Pharmaceutical Design Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
Current Vascular Pharmacology Gender Disparity in Pediatric Diseases
Current Molecular Medicine Clinical Vignettes: Integrated Care of Cancer Patients by Oncologists and Cardiologists
Current Cardiology Reviews